Verition Fund Management
GMAB icon

Verition Fund Management’s Genmab GMAB Stock Holding History

Verition Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,478
Closed -$1.3M – 3667
2025
Q3 		$1.3M Sell
42,478
-126,169
-75% -$3.07M 0.01% 2324
2025
Q2 		$3.48M Buy
168,647
+104,662
+164% +$2.15M 0.02% 1471
2025
Q1 		$1.25M Sell
63,985
-44,434
-41% -$932K 0.01% 1945
2024
Q4 		$2.26M Buy
108,419
+79,345
+273% +$1.74M 0.01% 1473
2024
Q3 		$709K Buy
+29,074
New +$777K ﹤0.01% 2104
2023
Q1 		– Sell
-9,468
Closed -$401K – 2305
2022
Q4 		$401K Buy
+9,468
New +$390K 0.01% 1352
2021
Q3 		– Sell
-5,637
Closed -$230K – 2062
2021
Q2 		$230K Buy
+5,637
New +$218K ﹤0.01% 1495

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Verition Fund Management's GMAB Position: Q4 2025 in Review

Verition Fund Management sold out of Genmab (GMAB) in Q4 2025, closing a stake of 42,478 shares — an estimated $1.3M sold.

Verition Fund Management first reported a position in GMAB in Q2 2021 and held it in 7 quarters. The position peaked at $3.48M in Q2 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • Verition Fund Management reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 42,478 Genmab shares in Q4 2025, an estimated $1.3M.
  • Verition Fund Management first reported a position in Genmab in Q2 2021 and held it in 7 quarters.
  • Verition Fund Management's Genmab position peaked at $3.48M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.